Pharmaceutical

Filter

Current filters:

None

Popular Filters

6679 to 6703 of 7117 results

Astex to return epigenetics project to GSK

17-01-2012

Astex Pharmaceuticals (Nasdaq: ASTX) says that the multi-year collaboration to discover cancer therapeutics…

Astex PharmaceuticalsGlaxoSmithKlineLicensingOncologyPharmaceuticalSuperGen

Adequate global standards for registry reports required, say IQWiG staffers

17-01-2012

Different formats are available for reporting the results of clinical trials. In an article just published…

BiotechnologyEuropePharmaceuticalRegulationResearch

Strong data on Phytopharm’s Cogane in ALS

17-01-2012

UK drug developer Phytopharm (LSE: PYM) yesterday announced preliminary data indicating that Cogane (PYM…

CoganeNeurologicalPharmaceuticalPhytopharmResearch

MediciNova collaborates on ibudilast

17-01-2012

California, USA-based Japanese bio-venture company MediciNova (Nasdaq: MNOV and TYO: 4875) and the University…

ibudilastMediciNovaNeurologicalPharmaceuticalResearch

German pharma hails successful 2011; views AMNOG

16-01-2012

The German pharmaceutical industry can be proud of its progress last year, said Birgit Fischer, director…

EuropeMarkets & MarketingPharmaceuticalPricingRegulation

Patent expiry of key blockbuster drugs good news for generics manufacturers, says F&S

16-01-2012

The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing…

GenericsMarkets & MarketingPatentsPharmaceutical

Two UK product launches

16-01-2012

Danish drugmaker Lundbeck (LUND: DC) announced yesterday that Sycrest (asenapine) is being launched in…

Anti-viralsEuropeIntelenceJanssenJohnson & JohnsonLundbeckMarkets & MarketingNeurologicalPharmaceuticalSaphrisSycrest

Type 1 diabetes discovery by UK scientists

16-01-2012

Scientists in the UK may have uncovered new evidence which it is hoped could eventually help diagnose…

DiabetesPharmaceuticalResearch

Lundbeck manufacturing cost achievements rewarded

16-01-2012

Danish drugmaker Lundbeck A/S (LUND: DC) says it has crowned six years of focused efforts on productivity…

FinancialLundbeckPharmaceutical

FDA completes work on three drug user fee programs

16-01-2012

The US Food and Drug Administration has completed its recommendations for three user fee programs that…

BiotechnologyFinancialGenericsNorth AmericaPharmaceuticalRegulation

Otsuka Pharma and UCB re-focus collaboration

16-01-2012

Japan’s Otsuka Pharmaceutical (TYO: 4768) and Belgian drugmaker UCB (Euronext Brussels: UCB) have…

Asia-PacificCimziaImmunologicalsKeppraLicensingNeurologicalOtsukaPharmaceuticalResearchrotigotineUCB

Sobi buys rights to novel neonatology treatment

16-01-2012

Stockholm-based Swedish Orphan Biovitrum (STO: SOBI) has signed a global licensing agreement with the…

BumetanideCardio-vascularLicensingNeurologicalOnly for Children PharmaceuticalsPharmaceuticalSwedish Orphan Biovitrum

CVS Caremark settles over deceptive drug pricing

15-01-2012

US pharmacy health care provider CVS Caremark (NYSE: CVS) will pay $5 million to settle Federal Trade…

CVS CaremarkLegalNorth AmericaPharmaceuticalPricing

New data on Rasilez in combination with certain BP drugs

15-01-2012

Researchers at St Michael's Hospital in Toronto, Canada, have published the first detailed figures showing…

Cardio-vascularPharmaceuticalRasilezResearch

Nearly 300 drugs for children under development in USA

15-01-2012

America’s biopharmaceutical companies are researching 282 medicines to help meet the unique health…

North AmericaPharmaceuticalResearch

A lot of user fee issues in USA

15-01-2012

2012 has only just begun, but the US Congress, the Food and Drug Administration and several health care…

BiotechnologyGenericsNorth AmericaPharmaceuticalPoliticsRegulation

Singapore pharma and health care market

15-01-2012

Headline expenditure projections from Business Monitor International for Singapore show that spending…

Asia-PacificMarkets & MarketingPharmaceutical

Novartis cuts jobs, takes $1.22 billion charges

13-01-2012

In anticipation of the blockbuster antihypertensive Diovan’s (valsartan) patent expiration and an…

DiovanFinancialManagementNovartisPatentsPharmaceuticalRasilezTekturna

NovAliX in drug discovery collaboration with Teijin Pharma

13-01-2012

French company NovAliX has entered into a multi-target integrated drug discovery collaboration with Japanese…

Asia-PacificEuropeNovAliXPharmaceuticalResearchTeijin

Licensing deal for Basilea in sight

13-01-2012

The completion of the pneumonia data audit and confirmation of the timeline for Switzerland-based Basilea’s…

Antibiotics and Infectious diseasesBasilea PharmaceuticaceftobiproleDermatologicalsLicensingPharmaceuticalResearchToctino

FDA gives Hemispherx time to respond to CRL

12-01-2012

Shares of USA-based Hemispherx Biopharma (NYSE Amex: HEB) rose 14% to $0.24 on Wednesday, after the company…

AmpligenHemispherx BioPharmaImmunologicalsNorth AmericaPharmaceuticalRegulation

GlaxoSmithKline challenges Argentina court ruling

12-01-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says it disagrees with the recent court ruling in favor of…

FinancialGlaxoSmithKlineLegalPharmaceuticalSouth AmericaSynflorixVaccines

Covance links with Inserm on R&D

12-01-2012

USA-based contract research organization Covance (NYSE: CVD) has signed a four-year scientific collaboration…

CovanceEuropeInsermPharmaceuticalResearch

6679 to 6703 of 7117 results

Parexel

Parexel

Back to top